Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 10/10

vs
industry
vs
history
Cash-to-Debt No Debt
NYSE:VEEV's Cash-to-Debt is ranked higher than
80% of the 1995 Companies
in the Global Health Information Services industry.

( Industry Median: 4.27 vs. NYSE:VEEV: No Debt )
Ranked among companies with meaningful Cash-to-Debt only.
NYSE:VEEV' s Cash-to-Debt Range Over the Past 10 Years
Min: No Debt  Med: No Debt Max: No Debt
Current: No Debt
Equity-to-Asset 0.77
NYSE:VEEV's Equity-to-Asset is ranked higher than
73% of the 1912 Companies
in the Global Health Information Services industry.

( Industry Median: 0.60 vs. NYSE:VEEV: 0.77 )
Ranked among companies with meaningful Equity-to-Asset only.
NYSE:VEEV' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.38  Med: 0.75 Max: 0.78
Current: 0.77
0.38
0.78
Interest Coverage No Debt
NYSE:VEEV's Interest Coverage is ranked higher than
81% of the 1497 Companies
in the Global Health Information Services industry.

( Industry Median: 138.02 vs. NYSE:VEEV: No Debt )
Ranked among companies with meaningful Interest Coverage only.
NYSE:VEEV' s Interest Coverage Range Over the Past 10 Years
Min: No Debt  Med: No Debt Max: No Debt
Current: No Debt
Piotroski F-Score: 7
Altman Z-Score: 27.52
Beneish M-Score: -2.75
WACC vs ROIC
10.28%
249.90%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 22.62
NYSE:VEEV's Operating Margin % is ranked higher than
87% of the 1940 Companies
in the Global Health Information Services industry.

( Industry Median: 5.13 vs. NYSE:VEEV: 22.62 )
Ranked among companies with meaningful Operating Margin % only.
NYSE:VEEV' s Operating Margin % Range Over the Past 10 Years
Min: 10.84  Med: 19.53 Max: 23.18
Current: 22.62
10.84
23.18
Net Margin % 21.23
NYSE:VEEV's Net Margin % is ranked higher than
91% of the 1940 Companies
in the Global Health Information Services industry.

( Industry Median: 3.84 vs. NYSE:VEEV: 21.23 )
Ranked among companies with meaningful Net Margin % only.
NYSE:VEEV' s Net Margin % Range Over the Past 10 Years
Min: 6.9  Med: 13.1 Max: 21.23
Current: 21.23
6.9
21.23
ROE % 18.15
NYSE:VEEV's ROE % is ranked higher than
79% of the 1869 Companies
in the Global Health Information Services industry.

( Industry Median: 6.75 vs. NYSE:VEEV: 18.15 )
Ranked among companies with meaningful ROE % only.
NYSE:VEEV' s ROE % Range Over the Past 10 Years
Min: 6.63  Med: 11.88 Max: 18.63
Current: 18.15
6.63
18.63
ROA % 13.65
NYSE:VEEV's ROA % is ranked higher than
87% of the 2005 Companies
in the Global Health Information Services industry.

( Industry Median: 3.19 vs. NYSE:VEEV: 13.65 )
Ranked among companies with meaningful ROA % only.
NYSE:VEEV' s ROA % Range Over the Past 10 Years
Min: 8.48  Med: 10.26 Max: 28.63
Current: 13.65
8.48
28.63
ROC (Joel Greenblatt) % 332.46
NYSE:VEEV's ROC (Joel Greenblatt) % is ranked higher than
89% of the 1965 Companies
in the Global Health Information Services industry.

( Industry Median: 23.66 vs. NYSE:VEEV: 332.46 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
NYSE:VEEV' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 207.71  Med: 456.58 Max: 2726.55
Current: 332.46
207.71
2726.55
3-Year Revenue Growth Rate 27.10
NYSE:VEEV's 3-Year Revenue Growth Rate is ranked higher than
86% of the 1650 Companies
in the Global Health Information Services industry.

( Industry Median: 6.00 vs. NYSE:VEEV: 27.10 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
NYSE:VEEV' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 6.1  Med: 38.1 Max: 130.6
Current: 27.1
6.1
130.6
3-Year EBITDA Growth Rate 28.00
NYSE:VEEV's 3-Year EBITDA Growth Rate is ranked higher than
77% of the 1466 Companies
in the Global Health Information Services industry.

( Industry Median: 8.90 vs. NYSE:VEEV: 28.00 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
NYSE:VEEV' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 10.4  Med: 33 Max: 137.1
Current: 28
10.4
137.1
3-Year EPS without NRI Growth Rate 48.70
NYSE:VEEV's 3-Year EPS without NRI Growth Rate is ranked higher than
87% of the 1339 Companies
in the Global Health Information Services industry.

( Industry Median: 10.60 vs. NYSE:VEEV: 48.70 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
NYSE:VEEV' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0  Med: 46.3 Max: 234.7
Current: 48.7
0
234.7
GuruFocus has detected 1 Warning Sign with Veeva Systems Inc NYSE:VEEV.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» NYSE:VEEV's 30-Y Financials

Financials (Next Earnings Date: 2018-11-22 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q3 2017

VEEV Guru Trades in Q3 2017

Joel Greenblatt 181,483 sh (+319.64%)
Columbia Wanger 986,224 sh (+195.52%)
Pioneer Investments 108,473 sh (+48.72%)
Jim Simons 351,512 sh (+32.65%)
Ron Baron 48,882 sh (+23.20%)
Caxton Associates Sold Out
Steven Cohen 200,000 sh (-11.47%)
Paul Tudor Jones 3,985 sh (-67.47%)
» More
Q4 2017

VEEV Guru Trades in Q4 2017

Ron Baron 424,253 sh (+767.91%)
Pioneer Investments 218,940 sh (+101.84%)
Jim Simons 635,200 sh (+80.71%)
Steven Cohen Sold Out
Paul Tudor Jones Sold Out
Columbia Wanger 908,078 sh (-7.92%)
Joel Greenblatt 13,194 sh (-92.73%)
» More
Q1 2018

VEEV Guru Trades in Q1 2018

Steven Cohen 14,000 sh (New)
David Swensen 80,000 sh (New)
Paul Tudor Jones 11,818 sh (New)
Jim Simons 1,466,800 sh (+130.92%)
Ron Baron 536,762 sh (+26.52%)
Pioneer Investments 242,708 sh (+10.86%)
Joel Greenblatt Sold Out
» More
Q2 2018

VEEV Guru Trades in Q2 2018

Joel Greenblatt 20,152 sh (New)
Paul Tudor Jones 39,643 sh (+235.45%)
Ron Baron 590,565 sh (+10.02%)
Jim Simons 1,492,600 sh (+1.76%)
Pioneer Investments 244,070 sh (+0.56%)
David Swensen Sold Out
Steven Cohen 1,600 sh (-88.57%)
» More
» Details

Insider Trades

Latest Guru Trades with NYSE:VEEV

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Ron Baron 2018-06-30 Add 10.02%0.02%$69.42 - $84.53 $ 90.3319%590,565
Joel Greenblatt 2018-06-30 New Buy0.02%$69.42 - $84.53 $ 90.3319%20,152
David Swensen 2018-06-30 Sold Out 1.62%$69.42 - $84.53 $ 90.3319%0
Ron Baron 2018-03-31 Add 26.52%0.04%$54.32 - $77.88 $ 90.3340%536,762
David Swensen 2018-03-31 New Buy1.62%$54.32 - $77.88 $ 90.3340%80,000
Joel Greenblatt 2018-03-31 Sold Out 0.01%$54.32 - $77.88 $ 90.3340%0
Ron Baron 2017-12-31 Add 767.91%0.1%$54 - $62.97 $ 90.3353%424,253
Joel Greenblatt 2017-12-31 Reduce -92.73%0.14%$54 - $62.97 $ 90.3353%13,194
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Application Software » Health Information Services    NAICS: 511210    SIC: 8099
Compare:NAS:ATHN, NAS:HQY, NAS:MDSO, XTER:COP, NYSE:TDOC, SZSE:300253, NAS:CERN, NAS:PINC, NAS:OMCL, NAS:INOV, HKSE:02666, NYSE:EVH, SZSE:300451, NAS:QSII, NAS:TRHC, NAS:HSTM, NAS:RCM, TSE:3902, LSE:CRW, LSE:EMIS » details
Traded in other countries:VEE.Germany,
Headquarter Location:USA
Veeva Systems Inc is a provider of industry-specific, cloud-based software solutions for the life sciences industry.

Veeva Systems largely provides cloud-based software to customers in the life sciences industry for customer relationship, content, and data management. Veeva CRM is a suite of applications that help pharmaceutical and biotechnology companies market and sell products to healthcare providers. Veeva Vault, a product built on proprietary software, is a cloud-based application built to manage content and associated data.

Top Ranked Articles about Veeva Systems Inc

Verix Joins Veeva's Technology Partner Program
'Must-Have' Stocks The best investments are companies that offer 'must-have' products and services to their customers
“We try to own every one of them. Every single one. And if I had my druthers, I wouldn't own any other stocks in the year 2000. Because these are the only ones worth owning right now in this extremely difficult, extremely narrow stock market. They are the only ones that are going higher consistently in good days and bad. I love every one of them, just as I loathe the rest of the stock universe.”[1] Read more...
Research Report Identifies Veeva, TD Ameritrade Holding, Quest Diagnostics, Chesapeake Utilities, Standard Motor Products, and Quaker Chemical with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
US Markets Pointed to Open Low After Weak Economic Data Veeva Systems tops street forecast
U.S. stocks are going to open in red territory with the main indexes trading lower ahead of news about private-sector employment. The ADP National Employment report showed that it has slowed down in November, as employers added 190,000 jobs, which was higher than expected. Read more...

Ratios

vs
industry
vs
history
PE Ratio 86.85
VEEV's PE Ratio is ranked lower than
86% of the 1281 Companies
in the Global Health Information Services industry.

( Industry Median: 27.75 vs. VEEV: 86.85 )
Ranked among companies with meaningful PE Ratio only.
VEEV' s PE Ratio Range Over the Past 10 Years
Min: 54.79  Med: 87.96 Max: 504.29
Current: 86.85
54.79
504.29
Forward PE Ratio 53.76
VEEV's Forward PE Ratio is ranked lower than
81% of the 343 Companies
in the Global Health Information Services industry.

( Industry Median: 25.00 vs. VEEV: 53.76 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 86.85
VEEV's PE Ratio without NRI is ranked lower than
86% of the 1278 Companies
in the Global Health Information Services industry.

( Industry Median: 27.79 vs. VEEV: 86.85 )
Ranked among companies with meaningful PE Ratio without NRI only.
VEEV' s PE Ratio without NRI Range Over the Past 10 Years
Min: 54.79  Med: 87.96 Max: 504.29
Current: 86.85
54.79
504.29
Price-to-Owner-Earnings 76.11
VEEV's Price-to-Owner-Earnings is ranked lower than
82% of the 760 Companies
in the Global Health Information Services industry.

( Industry Median: 28.11 vs. VEEV: 76.11 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
VEEV' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 54.31  Med: 70.12 Max: 91.72
Current: 76.11
54.31
91.72
PB Ratio 12.34
VEEV's PB Ratio is ranked lower than
88% of the 1858 Companies
in the Global Health Information Services industry.

( Industry Median: 3.12 vs. VEEV: 12.34 )
Ranked among companies with meaningful PB Ratio only.
VEEV' s PB Ratio Range Over the Past 10 Years
Min: 5.5  Med: 9.56 Max: 20.44
Current: 12.34
5.5
20.44
PS Ratio 18.26
VEEV's PS Ratio is ranked lower than
93% of the 1840 Companies
in the Global Health Information Services industry.

( Industry Median: 2.60 vs. VEEV: 18.26 )
Ranked among companies with meaningful PS Ratio only.
VEEV' s PS Ratio Range Over the Past 10 Years
Min: 7.38  Med: 12.91 Max: 29.48
Current: 18.26
7.38
29.48
Price-to-Free-Cash-Flow 52.79
VEEV's Price-to-Free-Cash-Flow is ranked lower than
72% of the 750 Companies
in the Global Health Information Services industry.

( Industry Median: 30.05 vs. VEEV: 52.79 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
VEEV' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 28.36  Med: 54.84 Max: 237.38
Current: 52.79
28.36
237.38
Price-to-Operating-Cash-Flow 51.66
VEEV's Price-to-Operating-Cash-Flow is ranked lower than
80% of the 923 Companies
in the Global Health Information Services industry.

( Industry Median: 21.70 vs. VEEV: 51.66 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
VEEV' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 24.57  Med: 45.87 Max: 214.44
Current: 51.66
24.57
214.44
EV-to-EBIT 69.47
VEEV's EV-to-EBIT is ranked lower than
85% of the 1311 Companies
in the Global Health Information Services industry.

( Industry Median: 19.89 vs. VEEV: 69.47 )
Ranked among companies with meaningful EV-to-EBIT only.
VEEV' s EV-to-EBIT Range Over the Past 10 Years
Min: 34.1  Med: 58.9 Max: 149.5
Current: 69.47
34.1
149.5
EV-to-EBITDA 64.17
VEEV's EV-to-EBITDA is ranked lower than
88% of the 1413 Companies
in the Global Health Information Services industry.

( Industry Median: 15.96 vs. VEEV: 64.17 )
Ranked among companies with meaningful EV-to-EBITDA only.
VEEV' s EV-to-EBITDA Range Over the Past 10 Years
Min: 30.7  Med: 53.6 Max: 142.6
Current: 64.17
30.7
142.6
EV-to-Revenue 15.71
VEEV's EV-to-Revenue is ranked lower than
90% of the 1910 Companies
in the Global Health Information Services industry.

( Industry Median: 2.65 vs. VEEV: 15.71 )
Ranked among companies with meaningful EV-to-Revenue only.
VEEV' s EV-to-Revenue Range Over the Past 10 Years
Min: 6.5  Med: 12 Max: 29.8
Current: 15.71
6.5
29.8
PEG Ratio 3.32
VEEV's PEG Ratio is ranked lower than
67% of the 599 Companies
in the Global Health Information Services industry.

( Industry Median: 2.07 vs. VEEV: 3.32 )
Ranked among companies with meaningful PEG Ratio only.
VEEV' s PEG Ratio Range Over the Past 10 Years
Min: 1.55  Med: 2.3 Max: 3.32
Current: 3.32
1.55
3.32
Current Ratio 3.91
VEEV's Current Ratio is ranked higher than
75% of the 1957 Companies
in the Global Health Information Services industry.

( Industry Median: 1.93 vs. VEEV: 3.91 )
Ranked among companies with meaningful Current Ratio only.
VEEV' s Current Ratio Range Over the Past 10 Years
Min: 1.51  Med: 3.38 Max: 4.68
Current: 3.91
1.51
4.68
Quick Ratio 3.91
VEEV's Quick Ratio is ranked higher than
76% of the 1957 Companies
in the Global Health Information Services industry.

( Industry Median: 1.79 vs. VEEV: 3.91 )
Ranked among companies with meaningful Quick Ratio only.
VEEV' s Quick Ratio Range Over the Past 10 Years
Min: 1.51  Med: 3.38 Max: 4.68
Current: 3.91
1.51
4.68
Days Sales Outstanding 53.25
VEEV's Days Sales Outstanding is ranked lower than
60% of the 1879 Companies
in the Global Health Information Services industry.

( Industry Median: 68.11 vs. VEEV: 53.25 )
Ranked among companies with meaningful Days Sales Outstanding only.
VEEV' s Days Sales Outstanding Range Over the Past 10 Years
Min: 53.25  Med: 122.54 Max: 129.15
Current: 53.25
53.25
129.15
Days Payable 12.08
VEEV's Days Payable is ranked lower than
83% of the 1720 Companies
in the Global Health Information Services industry.

( Industry Median: 45.50 vs. VEEV: 12.08 )
Ranked among companies with meaningful Days Payable only.
VEEV' s Days Payable Range Over the Past 10 Years
Min: 9.35  Med: 11.99 Max: 21.38
Current: 12.08
9.35
21.38

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -2.70
VEEV's 3-Year Average Share Buyback Ratio is ranked higher than
53% of the 1387 Companies
in the Global Health Information Services industry.

( Industry Median: -3.30 vs. VEEV: -2.70 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
VEEV' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -3.4  Med: -2.7 Max: -2.6
Current: -2.7
-3.4
-2.6

Valuation & Return

vs
industry
vs
history
Price-to-Net-Cash 18.62
VEEV's Price-to-Net-Cash is ranked lower than
66% of the 626 Companies
in the Global Health Information Services industry.

( Industry Median: 11.44 vs. VEEV: 18.62 )
Ranked among companies with meaningful Price-to-Net-Cash only.
VEEV' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 10.16  Med: 16.83 Max: 24.47
Current: 18.62
10.16
24.47
Price-to-Net-Current-Asset-Value 15.47
VEEV's Price-to-Net-Current-Asset-Value is ranked lower than
74% of the 1240 Companies
in the Global Health Information Services industry.

( Industry Median: 6.50 vs. VEEV: 15.47 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
VEEV' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 7.81  Med: 13 Max: 19.07
Current: 15.47
7.81
19.07
Price-to-Tangible-Book 13.98
VEEV's Price-to-Tangible-Book is ranked lower than
80% of the 1555 Companies
in the Global Health Information Services industry.

( Industry Median: 4.26 vs. VEEV: 13.98 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
VEEV' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 7.71  Med: 11.31 Max: 18.84
Current: 13.98
7.71
18.84
Price-to-Intrinsic-Value-Projected-FCF 5.29
VEEV's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
89% of the 840 Companies
in the Global Health Information Services industry.

( Industry Median: 2.11 vs. VEEV: 5.29 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
VEEV' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 4.43  Med: 6.02 Max: 6.54
Current: 5.29
4.43
6.54
Price-to-Median-PS-Value 1.41
VEEV's Price-to-Median-PS-Value is ranked lower than
65% of the 1656 Companies
in the Global Health Information Services industry.

( Industry Median: 1.09 vs. VEEV: 1.41 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
VEEV' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.66  Med: 0.99 Max: 2
Current: 1.41
0.66
2
Price-to-Peter-Lynch-Fair-Value 3.47
VEEV's Price-to-Peter-Lynch-Fair-Value is ranked lower than
79% of the 402 Companies
in the Global Health Information Services industry.

( Industry Median: 1.80 vs. VEEV: 3.47 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
VEEV' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 2.73  Med: 2.89 Max: 3.52
Current: 3.47
2.73
3.52
Price-to-Graham-Number 7.34
VEEV's Price-to-Graham-Number is ranked lower than
90% of the 974 Companies
in the Global Health Information Services industry.

( Industry Median: 2.25 vs. VEEV: 7.34 )
Ranked among companies with meaningful Price-to-Graham-Number only.
VEEV' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 5.01  Med: 6.56 Max: 17.28
Current: 7.34
5.01
17.28
Earnings Yield (Greenblatt) % 1.44
VEEV's Earnings Yield (Greenblatt) % is ranked lower than
56% of the 2008 Companies
in the Global Health Information Services industry.

( Industry Median: 2.11 vs. VEEV: 1.44 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
VEEV' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 0.7  Med: 1.7 Max: 2.9
Current: 1.44
0.7
2.9
Forward Rate of Return (Yacktman) % 21.00
VEEV's Forward Rate of Return (Yacktman) % is ranked higher than
86% of the 833 Companies
in the Global Health Information Services industry.

( Industry Median: 9.82 vs. VEEV: 21.00 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
VEEV' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 20.8  Med: 21.1 Max: 21.2
Current: 21
20.8
21.2

More Statistics

Revenue (TTM) (Mil) $766.22
EPS (TTM) $ 1.04
Beta1.19
Volatility41.61%
52-Week Range $52.17 - 109.05
Shares Outstanding (Mil)144.51

Analyst Estimate

Jan19 Jan20 Jan21
Revenue (Mil $) 844 1,006 1,172
EBIT (Mil $) 204 265
EBITDA (Mil $) 281 273
EPS ($) 1.14 1.33 1.53
EPS without NRI ($) 1.14 1.33 1.53
EPS Growth Rate
(Future 3Y To 5Y Estimate)
15.91%
Dividends per Share ($)

Piotroski F-Score Details

Piotroski F-Score: 77
Positive ROAY
Positive CFROAY
Higher ROA yoyY
CFROA > ROAY
Lower Leverage yoyY
Higher Current Ratio yoyY
Less Shares Outstanding yoyN
Higher Gross Margin yoyY
Higher Asset Turnover yoyN

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}